OBJECTIVES:. Venovenous extracorporeal membrane oxygenation has been largely used in patients with refractory acute respiratory distress syndrome due to coronavirus disease 2019. Few data on long-term pulmonary function among venovenous extracorporeal membrane oxygenation survivors are available. DESIGN:. Retrospective, observational cohort. SETTING:. Two mixed medical-surgical tertiary (30 beds) and secondary (22 beds) ICUs. PATIENTS:. All critically ill adult coronavirus disease 2019 survivors treated with venovenous extracorporeal membrane oxygenation between March 10, and April 30, 2020. MEASUREMENTS AND MAIN RESULTS:. The last available lung function and 6-minute walking tests, performed after a median of 178 days (ranges, 72–232 d) fr...
OBJECTIVES/BACKGROUND:. Extracorporeal membrane oxygenation is used as rescue therapy for patients w...
International audienceBACKGROUND: Despite expanding use, knowledge on extracorporeal membrane oxygen...
The role of veno-venous extracorporeal membrane oxygenation therapy (V-V ECMO) in severe COVID-19 ac...
Objectives: The authors evaluated the outcome of adult patients with coronavirus disease 2019 (COVID...
BACKGROUND: Critical illness from COVID-19 is associated with prolonged hospitalization and high mor...
Abstract Objectives: The authors evaluated the outcome of adult patients with coronavirus disease 2...
Objectives:. To prospectively describe 1-year outcomes, with a focus on functional outcome, cognitiv...
OBJECTIVES:. Implantation of venovenous extracorporeal membrane oxygenation as an alternative to inv...
PURPOSE: Limited data are available on venovenous extracorporeal membrane oxygenation (ECMO) in pati...
Objectives: To assess long-term survival in adult patients with severe acute lung failure receiving ...
This cohort study examines the outcome of venovenous extracorporeal membrane oxygenation in 40 patie...
International audienceRationale: Long-term outcomes of patients with coronavirus disease (COVID-19)-...
Introduction: Despite improved management of patients with COVID-19, we still ignore whether pharmac...
OBJECTIVES/BACKGROUND:. Extracorporeal membrane oxygenation is used as rescue therapy for patients w...
International audienceBACKGROUND: Despite expanding use, knowledge on extracorporeal membrane oxygen...
The role of veno-venous extracorporeal membrane oxygenation therapy (V-V ECMO) in severe COVID-19 ac...
Objectives: The authors evaluated the outcome of adult patients with coronavirus disease 2019 (COVID...
BACKGROUND: Critical illness from COVID-19 is associated with prolonged hospitalization and high mor...
Abstract Objectives: The authors evaluated the outcome of adult patients with coronavirus disease 2...
Objectives:. To prospectively describe 1-year outcomes, with a focus on functional outcome, cognitiv...
OBJECTIVES:. Implantation of venovenous extracorporeal membrane oxygenation as an alternative to inv...
PURPOSE: Limited data are available on venovenous extracorporeal membrane oxygenation (ECMO) in pati...
Objectives: To assess long-term survival in adult patients with severe acute lung failure receiving ...
This cohort study examines the outcome of venovenous extracorporeal membrane oxygenation in 40 patie...
International audienceRationale: Long-term outcomes of patients with coronavirus disease (COVID-19)-...
Introduction: Despite improved management of patients with COVID-19, we still ignore whether pharmac...
OBJECTIVES/BACKGROUND:. Extracorporeal membrane oxygenation is used as rescue therapy for patients w...
International audienceBACKGROUND: Despite expanding use, knowledge on extracorporeal membrane oxygen...
The role of veno-venous extracorporeal membrane oxygenation therapy (V-V ECMO) in severe COVID-19 ac...